AAAAAA

   
Results: 1-13 |
Results: 13
ONCE-WEEKLY FLUCONAZOLE (150, 300, OR 450 MG) IN THE TREATMENT OF DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE TOENAIL
Authors: SCHER RK BRENEMAN D RICH P SAVIN RC FEINGOLD DS KONNIKOV N SHUPACK JL PINNELL S LEVINE N LOWE NJ ALY R ODOM RB GREER DL MORMAN MR BUCKO AD TSCHEN EH ELEWSKI BE SMITH EB
Citation: Rk. Scher et al., ONCE-WEEKLY FLUCONAZOLE (150, 300, OR 450 MG) IN THE TREATMENT OF DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE TOENAIL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 77-86
ONCE-WEEKLY FLUCONAZOLE (150, 300, OR 450 MG) IN THE TREATMENT OF DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE FINGERNAIL
Authors: DRAKE L BABEL D STEWART DM RICH P LING MR BRENEMAN D SCHER RK MARTIN AG PARISER DM PARISER RJ ELLIS CN KANG SW KATZ HI MCDONALD CJ MUGLIA J SAVIN RC WEBSTER G ELEWSKI BE LEYDEN JJ BUCKO AD TSCHEN EH HANIFIN JM MORMAN MR SHUPACK JL LEVINE N LOWE NJ BERGFELD WF CAMISA C FEINGOLD DS KONNIKOV N ODOM RB ALY R GREER DL
Citation: L. Drake et al., ONCE-WEEKLY FLUCONAZOLE (150, 300, OR 450 MG) IN THE TREATMENT OF DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE FINGERNAIL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 87-94
PHARMACOKINETICS OF 3 DOSES OF ONCE-WEEKLY FLUCONAZOLE (150, 300, AND450 MG) IN DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE TOENAIL
Authors: RICH P SCHER RK BRENEMAN D SAVIN RC FEINGOLD DS KONNIKOV N SHUPACK JL PINNELL S LEVINE N LOWE NJ ALY R ODOM RB GREER DL MORMAN MR BUCKO AD TSCHEN EH ELEWSKI BE SMITH EB HILBERT J
Citation: P. Rich et al., PHARMACOKINETICS OF 3 DOSES OF ONCE-WEEKLY FLUCONAZOLE (150, 300, AND450 MG) IN DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE TOENAIL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 103-109
PHARMACOKINETICS OF 3 ONCE-WEEKLY DOSAGES OF FLUCONAZOLE (150, 300, OR 450 MG) IN DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE FINGERNAIL
Authors: SAVIN RC DRAKE L BABEL D STEWART DM RICH P LING MR BRENEMAN D SCHER RK MARTIN AG PARISER DM PARISER RJ ELLIS CN KANG SW FRIEDMAN D KATZ HI MCDONALD CJ MUGLIA J WEBSTER G ELEWSKI BE LEYDEN JJ BUCKO AD TSCHEN EH HANIFIN JM MORMAN MR SHUPACK JL LEVINE N LOWE NJ BERGFELD WF CAMISA C FEINGOLD DS KONNIKOV N ODOM RB ALY R GREER DL HILBERT J
Citation: Rc. Savin et al., PHARMACOKINETICS OF 3 ONCE-WEEKLY DOSAGES OF FLUCONAZOLE (150, 300, OR 450 MG) IN DISTAL SUBUNGUAL ONYCHOMYCOSIS OF THE FINGERNAIL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 110-116
ADMINISTRATION OF DAB(389)IL-2 TO PATIENTS WITH RECALCITRANT PSORIASIS - A DOUBLE-BLIND, PHASE-II MULTICENTER TRIAL
Authors: BAGEL J GARLAND WT BRENEMAN D HOLICK M LITTLEJOHN TW CROSBY D FAUST H FIVENSON D NICHOLS J
Citation: J. Bagel et al., ADMINISTRATION OF DAB(389)IL-2 TO PATIENTS WITH RECALCITRANT PSORIASIS - A DOUBLE-BLIND, PHASE-II MULTICENTER TRIAL, Journal of the American Academy of Dermatology, 38(6), 1998, pp. 938-944
A MULTICENTER TRIAL OF CALCIPOTRIENE OINTMENT AND HALOBETASOL OINTMENT COMPARED WITH EITHER AGENT ALONE FOR THE TREATMENT OF PSORIASIS
Authors: LEBWOHL M SISKIN SB EPINETTE W BRENEMAN D FUNICELLA T KALB R MOORE J
Citation: M. Lebwohl et al., A MULTICENTER TRIAL OF CALCIPOTRIENE OINTMENT AND HALOBETASOL OINTMENT COMPARED WITH EITHER AGENT ALONE FOR THE TREATMENT OF PSORIASIS, Journal of the American Academy of Dermatology, 35(2), 1996, pp. 268-269
CALCIPOTRIENE OINTMENT APPLIED ONCE A BAY FOR PSORIASIS - A DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY
Authors: PARISER DM PARISER RJ BRENEMAN D LEBWOHL M KALB R MOORE J MOSS H PARKER C FIEDLER V
Citation: Dm. Pariser et al., CALCIPOTRIENE OINTMENT APPLIED ONCE A BAY FOR PSORIASIS - A DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY, Archives of dermatology, 132(12), 1996, pp. 1527-1527
RESPONSE TO TOTAL SKIN IRRADIATION FOR MYCOSIS-FUNGOIDES ASSOCIATED WITH LYMPHOMATOID PAPULOSIS - RESPONSE
Authors: BRENEMAN J BRENEMAN D
Citation: J. Breneman et D. Breneman, RESPONSE TO TOTAL SKIN IRRADIATION FOR MYCOSIS-FUNGOIDES ASSOCIATED WITH LYMPHOMATOID PAPULOSIS - RESPONSE, International journal of radiation oncology, biology, physics, 32(1), 1995, pp. 274-274
CETIRIZINE AND ASTEMIZOLE THERAPY FOR CHRONIC IDIOPATHIC URTICARIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE TRIAL
Authors: BRENEMAN D BRONSKY EA BRUCE S KALIVAS JT KLEIN GL ROTH HL THARP MD TREGER C SOTER N
Citation: D. Breneman et al., CETIRIZINE AND ASTEMIZOLE THERAPY FOR CHRONIC IDIOPATHIC URTICARIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE TRIAL, Journal of the American Academy of Dermatology, 33(2), 1995, pp. 192-198
CALCIPOTRIENE OINTMENT 0.005-PERCENT FOR PSORIASIS - A SAFETY AND EFFICACY STUDY
Authors: HIGHTON A QUELL J BRENEMAN D CULLEN S GOFFE B GRIFFITHS C HUERTER C KINGSLEY D PIACQUADIO D PINCUS S ROGERS R SCHER RK
Citation: A. Highton et al., CALCIPOTRIENE OINTMENT 0.005-PERCENT FOR PSORIASIS - A SAFETY AND EFFICACY STUDY, Journal of the American Academy of Dermatology, 32(1), 1995, pp. 67-72
EFFECTIVENESS OF TOPICAL NALOXONE, AN OPIOID ANTAGONIST, IN THE TREATMENT OF PRURITUS ASSOCIATED WITH MYCOSIS-FUNGOIDES (MF) AND SEZARY-SYNDROME (SS)
Authors: PINCUS S OSEROFF A BRENEMAN D FOSS F KOH H DUVIC M VONDERHEID E COE B PHILLIPS SB BERNSTEIN JE
Citation: S. Pincus et al., EFFECTIVENESS OF TOPICAL NALOXONE, AN OPIOID ANTAGONIST, IN THE TREATMENT OF PRURITUS ASSOCIATED WITH MYCOSIS-FUNGOIDES (MF) AND SEZARY-SYNDROME (SS), Journal of investigative dermatology, 104(4), 1995, pp. 661-661
BCL-2 ONCOPROTEIN DISTINGUISHES BENIGN FROM MALIGNANT IN CUTANEOUS LYMPHOID LESION BIOPSIES
Authors: CHILDRESS L UTZ G CUALING H DEBOWSKY T BRENEMAN D BRENEMAN J STEELE P
Citation: L. Childress et al., BCL-2 ONCOPROTEIN DISTINGUISHES BENIGN FROM MALIGNANT IN CUTANEOUS LYMPHOID LESION BIOPSIES, Laboratory investigation, 70(1), 1994, pp. 10000105-10000105
SEZARY CELL EXPRESSION IN MYCOSIS-FUNGOIDES
Authors: WIBOWO A MIKHAEL A STROOP DM HILL J REISINGER J BRENEMAN D HURTUBISE P STEELE P YOCHMAN L SCHUMACHER HR
Citation: A. Wibowo et al., SEZARY CELL EXPRESSION IN MYCOSIS-FUNGOIDES, Blood, 84(10), 1994, pp. 10000598-10000598
Risultati: 1-13 |